Indian Biotechnology Industry Report

Publication Date	January 2007
Publisher	Cygnus
Product Type	Report
Pages	144
ISBN Number	not applicable
Product Code	CYG00004

Buy this product or for assistance call +44 20 7060 7474

OTHER£400.00$665 | €448

FAX Order above formats by FAX

Summary

The revenue of the Indian biotechnology industry reached Rs65,210 million in 2005-06, up 37.42% from Rs 47,450 million in 2004-05. In 2005-06, as many as ten Indian companies reported a revenue of Rs1,000 million and above, compared to six companies in 2004-05. In 2005-06, Biopharmaceuticals accounted for 72.20% of industry revenue, followed by bioservices (11.04%), agriculture sector (9.17%), bioindustry (5.75%) and bioinformatics (1.84%).The report on Indian Biotechnology covers the industry size and its growth over the past few years. The segments of the industry along with growth drivers and the issues and challenges of the industry are briefed. The core technologies in the industry and the major players of the industry are also discussed with their profiles. The regulatory environment and the associated bodies are mentioned and the critical success factors in the industry are highlighted.

This report also has the details on emerging trends in the industry and the opportunities for India and to end the report an outlook for the industry is also given. The report will be useful to the biotech industry and especially companies in biopharma, agri-biotechnology, industrial biotechnology, bio-services and bioinformatics in understanding this industry in a better way. It will also be useful to the government department and agencies working in the field of biotechnology to get an insight of the biopharma industry. The educational institutes may also use this information for their academic purpose to have in-depth industry knowledge. Other research bodies, industry experts, associations & consortia of the industry and consulting organizations may also benefit through the information given in the report. The report has been prepared from numerous sources which include: Publication of the industry, industry interactions, websites, and proprietary and subscribed databases. Due diligence and adequate care has been taken in the report to check and validate the figures used.

Content

1. Executive Summary
2. Highlights
3. Biotech Industry - Global Overview
- 3.1 Introduction
- 3.2 Industry growth
  - 3.2.1 Concentric industry
  - 3.2.2 Industry analysis
  - 3.2.3 Research and development expenditure
  - 3.2.4 Strength of the players
  - 3.2.5 Financial flow
  - 3.2.6 NASDAQ biotech index
- 3.3 Top ten biotech companies
4. Indian Biotech Industry - Overview
- 4.1 Introduction
- 4.2 Milestones
- 4.3 The Indian Biotechnology Industry
  - 4.3.1 Size
  - 4.3.2 Relative position
  - 4.3.3 Industry segments
  - 4.3.4 Exports
- 4.4 IPOs - Start of a new era
- 4.5 Government Support
- 4.6 Funding
  - 4.6.1 Government Funding
  - 4.6.2 Private Funding
5. Growth Drivers
- 5.1 Introduction
- 5.2 Positive Regulatory Support
- 5.3 Availability of finance
- 5.4 Changing demographics & improved living standards
- 5.5 Growing Business Community
- 5.6 Growth of Related Industries
- 5.7 Knowledge Environment
- 5.8 Outsourcing
6. Major Players
- 6.1 Biocon
- 6.2 Serum Institute of India
- 6.3 Panacea Biotech
- 6.4 Venkateshwara Hatcheries
- 6.5 Rasi Seeds
- 6.6 Aventis Pharma Limited
7. Bharat Serums And Vaccines
- 6.8 Glaxo Smithkline Pharmaceuticals
- 6.9 Shantha Biotechnics
- 6.10 Wockhardt
7. Technology
- 7.1 Core technologies
  - 7.1.1 Bioprocessing
  - 7.1.2 Monoclonal antibody
  - 7.1.3 Cell/ tissue culture
  - 7.1.5 Recombinant DNA technology
  - 7.1.6 Protein engineering
  - 7.1.7 Biosensors
  - 7.1.8 Bio-Nanotechnology
  - 7.1.9 Microarrays
- 7.2 Other uses of biotechnology
- 7.3 Outlook
  - 7.3.1 Pharmacogenomics
  - 7.3.2 Metabolomics
  - 7.3.4 Gene therapy
  - 7.3.5 Immuno (Hybridoma) Technology
  - 7.3.6 Stem cell techniques:
  - 7.3.7 Nutraceuticals
  - 7.3.8 Bioremediation
  - 7.3.9 Bioinformatics
8. Major Clusters
- 8.1 Southern Region
  - 8.1.1 Andhra Pradesh-Hyderabad
  - 8.1.2 Karnataka-Bangalore
  - 8.1.3 Tamil Nadu-Chennai
- 8.2 Northern region
  - 8.2.1 National Capital Region- Delhi
  - 8.2.2 Uttar Pradesh (Lucknow) & Punjab (Chandigarh)
- 8.3 Western Region
  - 8.3.1 Maharashtra-Mumbai & Pune
  - 8.3.2 Gujarat
- 8.4 North Eastern Region
  - 8.4.1 West Bengal-Kolkata
  - 8.4.2 Assam- Gauhati
9. Issues And Challenges
- 9.1 Funding
- 9.2 Indian biotech start-ups & Foreign VCs
- 9.3 Biotech Manpower
- 9.4 Big pharma & biotechnology
- 9.5 Scientific community & Business acumen
- 9.6 Multiple regulators
10. Regulations
- 10.1 Regulatory bodies
  - 10.1.1 Organizational Structure of Relevant Institution
- 10.2 Regulatory Structure
- 10.4 Highlights of State Government Biotech Policies
11. Critical Success Factors
- 11.1 Research & Development
- 11.2 Infrastructure
  - 11.3.1 Premises and infrastructure
  - 11.3.2 Biotech clusters
  - 11.3.3 Effective networks
- 11.4 Mergers and Acquisitions
- 11.5 Product Portfolio
12. Future Outlook